title: Liver impairment after concomitant administration of bosentan and clarithromycin in systemic sclerosis.
authors.forename: Paola
authors.initials: P
authors.lastname: Caramaschi
authors.forename: Helal
authors.initials: H
authors.lastname: Mahamid
authors.forename: Lisa Maria
authors.initials: LM
authors.lastname: Bambara
authors.forename: Domenico
authors.initials: D
authors.lastname: Biasi
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D000077300:Bosentan; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000378:metabolism; D017291:Clarithromycin / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005385:Fingers / Q000473:pathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology; D008111:Liver Function Tests; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy*; D012883:Skin Ulcer / Q000209:etiology / Q000517:prevention & control; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D013449:Sulfonamides; D017291:Clarithromycin; D000077300:Bosentan